Loading…
EnSilica was awarded a fully funded three-month feasibility study by a U.S. healthcare technology company to develop a wireless biosensing and therapeutic controller ASIC, valued at about US$200,000.
“The feasibility study has a value of approximately US$200,000”stockopedia.com
Summarized from public sources; check the original articles before acting on it.